Nuwellis, Inc. (NUWE) stock
NUWENasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$3.89−0.21 (-5.12%)
Close on Nov 18, 2026Market cap $2.23MP/E –Yield –
Nuwellis operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Nuwellis's operating income for the twelve months ending Jun 30, 2026 was -$12.88M. For fiscal 2025 it was -$11.11M. The highest annual figure on record is -$10.99M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.11M | – |
| FY2024 | Dec 31, 2024 | -$10.99M | – |
| FY2023 | Dec 31, 2023 | -$17.63M | – |
| FY2022 | Dec 31, 2022 | -$17.17M | – |
| FY2021 | Dec 31, 2021 | -$19.53M | – |
| FY2020 | Dec 31, 2020 | -$17.03M | – |
| FY2019 | Dec 31, 2019 | -$18.11M | – |
| FY2018 | Dec 31, 2018 | -$17.04M | – |
| FY2017 | Dec 31, 2017 | -$14.81M | – |
| FY2016 | Dec 31, 2016 | -$15.66M | – |
| FY2015 | Dec 31, 2015 | -$25.96M | – |
| FY2014 | Dec 31, 2014 | -$25.79M | – |
| FY2013 | Dec 31, 2013 | -$22.87M | – |
| FY2012 | Dec 31, 2012 | -$14.87M | – |
| FY2011 | Dec 31, 2011 | -$16.56M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.17M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.57M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.44M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.70M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.91M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.06M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.39M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.53M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.32M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.75M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.59M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.16M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.02M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.85M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.53M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.92M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.30M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.42M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.33M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.25M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.73M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.22M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.29M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.26M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.92M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.57M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.45M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.51M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.43M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.73M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.25M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.25M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.18M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.35M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.14M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.86M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.50M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.31M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.06M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.06M | – |
See a number that looks wrong?